Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PRPO | US
0.01
0.05%
Healthcare
Diagnostics & Research
30/06/2024
06/03/2026
26.53
26.60
26.60
26.00
Precipio Inc. a healthcare solutions company provides diagnostic products reagents and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven Connecticut.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
68.5%1 month
72.3%3 months
55.7%6 months
78.5%-
15.43
0.82
0.10
0.07
-1.15
0.59
-
-4.30M
39.33M
39.33M
-
-27.22
-
25.70
-29.22
1.07
0.63
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
4.69
Range1M
7.48
Range3M
8.74
Rel. volume
0.54
Price X volume
276.78K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Neuronetics Inc | STIM | Diagnostics & Research | 1.38 | 41.82M | -2.13% | n/a | 323.03% |
| BioTelemetry Inc | BEAT | Diagnostics & Research | 1.4 | 37.19M | 0.00% | n/a | 0.00% |
| STAR EQUITY HOLDINGS INC | STRR | Diagnostics & Research | 10.07 | 32.44M | 0.20% | n/a | 26.85% |
| Biomerica Inc | BMRA | Diagnostics & Research | 1.92 | 32.30M | -2.54% | n/a | 13.22% |
| MYnd Analytics Inc | MYND | Diagnostics & Research | 0.4269 | 19.49M | 1.62% | n/a | 117.50% |
| VolitionRx Limited | VNRX | Diagnostics & Research | 0.1981 | 18.25M | 0.66% | n/a | -26.88% |
| Mainz Biomed B.V. Ordinary Shares | MYNZ | Diagnostics & Research | 0.83 | 18.17M | 2.29% | n/a | 228.39% |
| bioAffinity Technologies Inc. | BIAF | Diagnostics & Research | 1.04 | 14.03M | 0.97% | n/a | 40.20% |
| INOTIV INC | NOTV | Diagnostics & Research | 0.3691 | 9.60M | 11.17% | n/a | 236.01% |
| XWEL | XWEL | Diagnostics & Research | 1.32 | 6.94M | -8.97% | n/a | 126.14% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.21 | 32.29M | -3.49% | 0.03 | 16.03% |
| Reading International Inc | RDI | Media - Diversified | 0.9993 | 28.21M | -2.98% | n/a | 4054.78% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.6345 | 12.26M | -10.63% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.4799 | 3.78M | -0.68% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.397 | 3.78M | -1.73% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.39 | 1.32M | -3.24% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.15 | - | Cheaper |
| Ent. to Revenue | 0.59 | - | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.82 | 77.50 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 55.70 | - | Par |
| Debt to Equity | 0.10 | -14.36 | Expensive |
| Debt to Assets | 0.07 | 0.34 | Cheaper |
| Market Cap | 39.33M | - | Emerging |